Open original FDA record ↗Recall record
- FDA identifier
- Z-1132-2018
- Company in FDA record
- NxStage Medical, Inc.
- FDA record creation date
- Mar 19, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Using different fluid formulations of NxStage PureFlow B Solution at the same time during treatment may cause patient health risk. The NxStage PureFlow B Solution is for use with systems that use one premixed dialysate during hemodialysis. The original labeling did not warn against mixing dialysate formulations and did not instruct staff to verify that the fluid is flowing during use.
Source facts
- Action
- Customers are advised to : 1. Always make sure when using PureFlow B Solution that fluid is flowing freely from all bags. 2. Recognize that any practice of hanging more than one fluid type at the same time is not an intended use of the NxStage System One" (as it does not monitor fluid composition) and is not a labeled indication of PureFlow B solutions. 3. Please make sure that all users of PureFlow B Solution in your organization and other concerned persons are informed regarding this Field Safety Notice. 4. Complete the enclosed customer reply form and return it to NxStage. Returning the customer reply form promptly will confirm your receipt of this notification and prevent you from receiving repeat notices.
- Initiated
- 2017-11-10
- Root cause
- Labeling design
- Terminated
- 2019-12-06
- Distribution
- US nationwide distribution
- Recall number
- Z-1132-2018
- Recall status
- Terminated
- CDRH record ID
- 161806
- FDA record created
- 2018-03-19
- Recall event number
- 79276